Russia has developed an oncology drug based on doxorubicin with targeted delivery of the substance to a tumor, RIA Novosti reported with reference to Deputy Prime Minister Tatyana Golikova. It should be noted that "the drug is safer for heart function and has the ability to provide more effective drug treatment", and the start of its use is expected in 2029.

Russia has developed an oncology drug based on doxorubicin with targeted delivery of the substance to a tumor, RIA Novosti reported with reference to Deputy Prime Minister Tatyana Golikova. It should be noted that "the drug is safer for heart function and has the ability to provide more effective drug treatment", and the start of its use is expected in 2029.